Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LQ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MD.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MB.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.222NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.470NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.31 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.51 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.122.5 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.40.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
GK.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.13.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.54NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.196NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.57NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.459NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.117NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.381NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.237NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.382NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.395NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.153NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.391NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.448NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Q.1 (Alpha)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.46 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.99 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.120.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.528NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.91 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.617NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used